Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 33

1.

Comparative effectiveness of alternative prostate-specific antigen--based prostate cancer screening strategies: model estimates of potential benefits and harms.

Gulati R, Gore JL, Etzioni R.

Ann Intern Med. 2013 Feb 5;158(3):145-53. doi: 10.7326/0003-4819-158-3-201302050-00003.

PMID:
23381039
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force.

Lin K, Lipsitz R, Miller T, Janakiraman S; U.S. Preventive Services Task Force.

Ann Intern Med. 2008 Aug 5;149(3):192-9. Review.

PMID:
18678846
[PubMed - indexed for MEDLINE]
3.

Screening for prostate cancer.

Ilic D, Neuberger MM, Djulbegovic M, Dahm P.

Cochrane Database Syst Rev. 2013 Jan 31;1:CD004720. doi: 10.1002/14651858.CD004720.pub3. Review.

PMID:
23440794
[PubMed - indexed for MEDLINE]
4.

Should prostate-specific antigen screening be offered to asymptomatic men?

van Vugt HA, Bangma CH, Roobol MJ.

Expert Rev Anticancer Ther. 2010 Jul;10(7):1043-53. doi: 10.1586/era.10.64. Review.

PMID:
20645694
[PubMed - indexed for MEDLINE]
5.

Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).

Schröder FH.

Can J Urol. 2005 Feb;12 Suppl 1:2-6; discussion 92-3. Review.

PMID:
15780157
[PubMed - indexed for MEDLINE]
6.

American Urological Association (AUA) guideline on prostate cancer detection: process and rationale.

Carter HB.

BJU Int. 2013 Sep;112(5):543-7. doi: 10.1111/bju.12318. Review.

PMID:
23924423
[PubMed - indexed for MEDLINE]
7.

Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force.

Chou R, Croswell JM, Dana T, Bougatsos C, Blazina I, Fu R, Gleitsmann K, Koenig HC, Lam C, Maltz A, Rugge JB, Lin K.

Ann Intern Med. 2011 Dec 6;155(11):762-71. doi: 10.7326/0003-4819-155-11-201112060-00375. Epub 2011 Oct 7. Review.

PMID:
21984740
[PubMed - indexed for MEDLINE]
8.

Population screening for prostate cancer and emerging concepts for young men.

Moul JW.

Clin Prostate Cancer. 2003 Sep;2(2):87-97. Review.

PMID:
15040869
[PubMed - indexed for MEDLINE]
9.

Risk-based prostate cancer screening.

Zhu X, Albertsen PC, Andriole GL, Roobol MJ, Schröder FH, Vickers AJ.

Eur Urol. 2012 Apr;61(4):652-61. doi: 10.1016/j.eururo.2011.11.029. Epub 2011 Nov 24. Review.

PMID:
22134009
[PubMed - indexed for MEDLINE]
10.

[Focus on the screening for prostate cancer by PSA].

Roumeguère T, Van Velthoven R.

Rev Med Brux. 2013 Sep;34(4):311-9. Review. French.

PMID:
24195246
[PubMed - indexed for MEDLINE]
11.

PSA-based screening for prostate cancer. Too many adverse effects.

[No authors listed]

Prescrire Int. 2012 Sep;21(130):215-7. Review.

PMID:
23016259
[PubMed - indexed for MEDLINE]
12.

Landmarks in prostate cancer screening.

Schröder FH.

BJU Int. 2012 Oct;110 Suppl 1:3-7. doi: 10.1111/j.1464-410X.2012.011428.x. Review.

PMID:
23046034
[PubMed - indexed for MEDLINE]
13.

[PSA-screening for prostate cancer--yes or no?].

Recker F, Kwiatkowski M.

Ther Umsch. 2004 Jun;61(6):353-8. Review. German.

PMID:
15253159
[PubMed - indexed for MEDLINE]
14.

An evidence review of active surveillance in men with localized prostate cancer.

Ip S, Dahabreh IJ, Chung M, Yu WW, Balk EM, Iovin RC, Mathew P, Luongo T, Dvorak T, Lau J.

Evid Rep Technol Assess (Full Rep). 2011 Dec;(204):1-341. Review.

PMID:
23126653
[PubMed - indexed for MEDLINE]
Free Article
15.

Active surveillance in men with localized prostate cancer: a systematic review.

Dahabreh IJ, Chung M, Balk EM, Yu WW, Mathew P, Lau J, Ip S.

Ann Intern Med. 2012 Apr 17;156(8):582-90. doi: 10.7326/0003-4819-156-8-201204170-00397. Epub 2012 Feb 20. Review.

PMID:
22351515
[PubMed - indexed for MEDLINE]
16.

Screening for prostate cancer with PSA testing: current status and future directions.

Croswell JM, Kramer BS, Crawford ED.

Oncology (Williston Park). 2011 May;25(6):452-60, 463. Review.

PMID:
21717898
[PubMed - indexed for MEDLINE]
17.

Screening for prostate cancer: early detection or overdetection?

Vickers AJ, Roobol MJ, Lilja H.

Annu Rev Med. 2012;63:161-70. doi: 10.1146/annurev-med-050710-134421. Epub 2011 Nov 3. Review.

PMID:
22053739
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation.

Humphrey LL, Deffebach M, Pappas M, Baumann C, Artis K, Mitchell JP, Zakher B, Fu R, Slatore CG.

Ann Intern Med. 2013 Sep 17;159(6):411-20. doi: 10.7326/0003-4819-159-6-201309170-00690. Review.

PMID:
23897166
[PubMed - indexed for MEDLINE]
19.

Prostate cancer overdiagnosis and overtreatment.

Klotz L.

Curr Opin Endocrinol Diabetes Obes. 2013 Jun;20(3):204-9. doi: 10.1097/MED.0b013e328360332a. Review.

PMID:
23609043
[PubMed - indexed for MEDLINE]
20.

PSA screening: a public health dilemma.

Mandelson MT, Wagner EH, Thompson RS.

Annu Rev Public Health. 1995;16:283-306. Review.

PMID:
7543756
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk